Walleye Capital’s Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares BIOX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-95,046
Closed -$20K 1074
2020
Q2
$20K Buy
95,046
+41,420
+77% +$9.79K ﹤0.01% 577
2020
Q1
$8K Buy
+53,626
New +$8.83K ﹤0.01% 796

Walleye Capital's BIOX.WS Position: Q3 2020 in Review

Walleye Capital sold out of Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares (BIOX.WS) in Q3 2020, closing a stake of 95,046 shares — an estimated $20K sold.

Walleye Capital first reported a position in BIOX.WS in Q1 2020 and held it in 2 quarters. The position peaked at $20K in Q2 2020. 0 funds tracked by Wall St. Rank hold BIOX.WS as of Q3 2020.

  • Walleye Capital reported no remaining Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position as of Q3 2020 after selling out during the quarter.
  • Walleye Capital sold 95,046 Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares shares in Q3 2020, an estimated $20K.
  • Walleye Capital first reported a position in Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares in Q1 2020 and held it in 2 quarters.
  • Walleye Capital's Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares position peaked at $20K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Bioceres Crop Solutions Corp Warrants, exercisable for ordinary shares as of Q3 2020.

Based on Walleye Capital's 13F filing for Q3 2020, filed 16 Nov 2020.